BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18575626)

  • 1. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
    Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D
    PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
    Premji Z; Umeh RE; Owusu-Agyei S; Esamai F; Ezedinachi EU; Oguche S; Borrmann S; Sowunmi A; Duparc S; Kirby PL; Pamba A; Kellam L; Guiguemdé R; Greenwood B; Ward SA; Winstanley PA
    PLoS One; 2009 Aug; 4(8):e6682. PubMed ID: 19690618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
    Dunyo S; Sirugo G; Sesay S; Bisseye C; Njie F; Adiamoh M; Nwakanma D; Diatta M; Janha R; Sisay Joof F; Temple B; Snell P; Conway D; Walton R; Cheung YB; Milligan P
    PLoS One; 2011; 6(6):e17371. PubMed ID: 21666744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
    Falade CO; Dada-Adegbola HO; Ogunkunle OO; Oguike MC; Nash O; Ademowo OG
    Med Princ Pract; 2014; 23(3):204-11. PubMed ID: 24732940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
    Mutabingwa TK; Muze K; Ord R; Briceño M; Greenwood BM; Drakeley C; Whitty CJ
    PLoS One; 2009; 4(4):e5138. PubMed ID: 19352498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
    Meremikwu M; Alaribe A; Ejemot R; Oyo-Ita A; Ekenjoku J; Nwachukwu C; Ordu D; Ezedinachi E
    Malar J; 2006 May; 5():43. PubMed ID: 16704735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial.
    Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C
    Malar J; 2014 Jan; 13():9. PubMed ID: 24393479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.
    Toure OA; Assi SB; N'Guessan TL; Adji GE; Ako AB; Brou MJ; Ehouman MF; Gnamien LA; Coulibaly MA; Coulibaly B; Beourou S; Bassinka I; Soumahoro A; Kadjo F; Tano MA
    Malar J; 2014 Nov; 13():439. PubMed ID: 25409546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
    Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
    Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.
    van den Broek I; Kitz C; Al Attas S; Libama F; Balasegaram M; Guthmann JP
    Malar J; 2006 Nov; 5():113. PubMed ID: 17125496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
    Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
    Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
    Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S
    Malar J; 2007 Nov; 6():146. PubMed ID: 17996121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
    Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
    Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
    Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O
    Malar J; 2011 Aug; 10():237. PubMed ID: 21838909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
    Fanello CI; Karema C; Avellino P; Bancone G; Uwimana A; Lee SJ; d'Alessandro U; Modiano D
    PLoS One; 2008; 3(12):e4031. PubMed ID: 19112496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial.
    De la Hoz Restrepo F; Porras Ramírez A; Rico Mendoza A; Córdoba F; Rojas DP
    Rev Soc Bras Med Trop; 2012 Dec; 45(6):732-8. PubMed ID: 23295878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.